Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation (Q91554792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

title

Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

main subject

organ transplantation

1 reference

Zachary Fitch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Robin Schmitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Jean Kwun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Bernhard Hering

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Joren Madsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Stuart J Knechtle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

publication date

5 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

published in

Transplantation Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

115-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

Crossing the bridge: large animal models in translational transplantation research

23 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Recommendations of the expert panel on ethical issues in clinical trials of transplant tolerance. National Institute of Allergy and Infectious Diseases of the National Institutes of Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Primate models in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Nonhuman primate models of transplant tolerance: closer to the holy grail.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Nonhuman primate models of human immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

The application of high-dose interleukin-2 for metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance induction after organ transplantation, "delayed tolerance," via the mixed chimerism approach: planting flowers in a battle field

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance of Vascularized Islet-Kidney Transplants in Rhesus Monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

HLA-mismatched renal transplantation without maintenance immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Organ-specific differences in achieving tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Revascularization in atherosclerotic renal artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

HLA-mismatched renal transplantation without maintenance immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Primate renal transplants using immunotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Genetic Construction and Characterization of an Anti-Monkey CD3 Single-Chain Immunotoxin with a Truncated Diphtheria Toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Metastable tolerance in nonhuman primates and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Memory T-cell-specific therapeutics in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Heterologous immunity provides a potent barrier to transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Virally-Induced Heterologous Immunity in Renal Transplant Recipients: Important or Inconsequential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Kidney after nonrenal transplantation-the impact of alemtuzumab induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Split tolerance induced by immunotoxin in a rhesus kidney allograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

BAFF is increased in renal transplant patients following treatment with alemtuzumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

inferred from DOI database lookup

7 January 2021

based on heuristic

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance: of mice and men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Platelets influence vascularized organ transplants from start to finish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

A novel monoclonal antibody to CD40 prolongs islet allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Pilot Study Evaluating Regulatory T Cell-Promoting Immunosuppression and Nonimmunogenic Donor Antigen Delivery in a Nonhuman Primate Islet Allotransplantation Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Update on CD40 and CD154 blockade in transplant models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Monotherapy with anti-CD40 ligand antibody (IDEC 131) for non-human primate allograft heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

An MHC-Defined Primate Model Reveals Significant Rejection of Bone Marrow After Mixed Chimerism Induction Despite Full MHC Matching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Summary of the US FDA approval of belatacept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Lymphodepletion and homeostatic proliferation: implications for transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

LFA-1-specific therapy prolongs allograft survival in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

The Role of OX40 (CD134) in T-Cell Memory Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerogenic dendritic cells and the quest for transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Regulating T Cell Behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Mesenchymal stem cells in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Predicting kidney graft failure by HLA antibodies: a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Human leukocyte antigen antibodies and chronic rejection: from association to causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CCR5 blockade modulates inflammation and alloimmunity in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Sirolimus Enhances the Magnitude and Quality of Viral-Specific CD8+ T-Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

mTOR regulates memory CD8 T-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Epstein-Barr virus and renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term lung transplantation in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Major histocompatibility complex genotyping with massively parallel pyrosequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Nonhuman primate transplant models finally evolve: detailed immunogenetic analysis creates new models and strengthens the old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Identification of a B cell signature associated with renal transplant tolerance in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Unique B cell differentiation profile in tolerant kidney transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Tolerance signatures in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Effects of brain death on organ quality and transplant outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Graft-specific immune cells communicate inflammatory immune responses after brain death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Donor brain death inhibits tolerance induction in miniature swine recipients of fully MHC-disparate pulmonary allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Advancing islet transplantation: from engraftment to the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

Prevention of nonimmunologic loss of transplanted islets in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2019.03.002

10.1016/J.TRRE.2019.03.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31027947%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference